With shares of CBS (NYSE:CBS) trading around $47, is CBS an OUTPERFORM, WAIT AND SEE or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:
T = Trends for a Stock’s Movement
CBS operates as a mass media company in the United States and internationally. The company operates in segments that include Entertainment, Cable Networks, Publishing, Local Broadcasting, and Outdoor. Consumers seek entertainment of various forms and through an array of platforms at an increasing rate. Through its segments, CBS is able to fulfill consumer needs as they continue to release content that excites the masses. Consumers around the world continue to seek varied forms of entertainment and CBS is dedicated to delivering amazing media, which can only lead to growth and rising profits well into the future.
NEW! Discover a new stock idea each week for less than the cost of 1 trade. CLICK HERE for your Weekly Stock Cheat Sheets NOW!T = Technicals on the Stock Chart are Strong
Hot International Companies To Own For 2015: Biogen Idec Inc(BIIB)
Biogen Idec Inc. discovers, develops, manufactures, and markets therapies for the treatment of neurodegenerative diseases, hemophilia, and autoimmune disorders in the United States and internationally. Its marketed products include the AVONEX for the treatment of relapsing multiple sclerosis (MS); RITUXAN for treating relapsed or refractory, CD20-positive, and B-cell Non-Hodgkin?s lymphoma (NHL); TYSABRI to treat relapsing MS; FUMADERM for the treatment of severe plaque psoriasis in adult patients; and FAMPYRA, an oral compound for the improvement of walking in adult patients with MS with walking disability. Biogen Idec Inc.?s products under Phase III consist of PEGylated interferon beta-1a designed to prolong the effects and reduce the dosing frequency of interferon beta-1a; BG-12 for the treatment of MS; Daclizumab, a monoclonal antibody in relapsing MS; Long-lasting factor IX and VIII fusion protein for the treatment of hemophilia B; GA101, a monoclonal antibody for t he treatment of chronic lymphocytic leukemia and NHL; and Dexpramipexole, an orally administered small molecule for the treatment of amyotrophic lateral sclerosis. The company?s Phase I clinical trial products include Anti-LINGO for use in multiple sclerosis, Neublastin for use in neuropathic pain, CD40L for use in systemic lupus erythematosus, ANTI-TWAEK humanized monoclonal antibody for TWEAK, and BIIB037 for use in Alzheimer's disease; and Phase II clinical trial product comprises OCRELIZUMAB, a humanized monoclonal antibody for treating CD20. It has collaboration agreements with Genentech, Inc.; Elan Pharma International, Ltd; Acorda Therapeutics, Inc.; Portola Pharmaceuticals, Inc.; Swedish Orphan Biovitrum AB; Abbott Biotherapeutics Corp; and Vernalis plc. The company was formerly known as IDEC Pharmaceuticals Corporation and changed its name to Biogen Idec Inc. in November 2003. Biogen Idec Inc. was founded in 1985 and is headquartered in Weston, Massachusetts.
Advisors' Opinion:- [By Sean Williams]
Monkey see, monkey do (better)
I believe the "wow" of Alkermes analyst day was the company's assertion that it's going to attempt to formulate a next-generation version of Biogen Idec's (NASDAQ: BIIB ) recently approved MS-relapse reducing drug Tecfidera. Without getting too technical, Tecfidera is a dimethyl fumarate prodrug, whereas Alkermes is attempting to develop a drug that'll convert to monomethyl fumarate, or MMF, in the body. The goal being to potentially develop an MS treatment that could be taken as little as once a day to help with patient dosing, and that's considerably safer than Tecfidera, especially for those who have to take the drug over the long term. Tecfidera in its own right is a considerably safer MS drug than many of its competitors, so this could be a tough drug to dethrone. Alkermes plans to initiate early-stage studies on its MMF prodrug by mid-2014. - [By Tom Rojas and Maria Armental var popups = dojo.query(".socialByline .popC"); ]
Biogen Idec Inc.(BIIB) said robust sales of its multiple-sclerosis treatments helped drive up earnings by 46% in the second quarter. Shares jumped 7.4% to $326 premarket.
- [By Brian Orelli]
George Scangos has turned around Biogen Idec (NASDAQ: BIIB ) . Shares have more than quadrupled since he took the helm in the middle of 2010. Focusing the company's pipeline by getting rid of fringe products was clearly a good move. Fellow Fool Sean Williams drafted him to head his fantasy biotech company, with which I completely concur.
- [By Maxx Chatsko]
This would no doubt have been a great step forward for patients if successful. The good news is that there are multiple treatments available for patients with B-Cell lymphoma.�Biogen Idec (NASDAQ: BIIB ) and Roche offer rituximab as a first-line combination treatment, while Sanofi offers alemtuzumab as a second line treatment. Rituximab brought in $7.2 billion in sales in 2012 -- making it one of the most successful drugs in the world (it is also approved for non-Hodgkin's lymphoma and rheumatoid arthritis). It is about to get much cheaper for patients, too. A total of 12 companies have lined up to commercialize generic versions once patents expire in Europe at the end of this year and in the United States in 2018. �
Top 5 Tech Stocks To Watch For 2014: Ellie Mae Inc (ELLI)
Ellie Mae, Inc., incorporated October 14, 2007, is a provider of on-demand automation solutions for the mortgage industry. The Company offers an end-to-end solution, delivered using a Software-as-a-Service model that serves as the core operating system for mortgage originators and spans customer relationship management, loan origination and business management. It also hosts the Ellie Mae Network that allows Encompass users to electronically conduct business transactions with the lenders and settlement service providers they work with to process and fund loans. The Company's offerings include range of Encompass services and the DataTrac mortgage management software system. On August 15, 2011, it completed the acquisition of Del Mar Datatrac,Inc. (DMD).
Using the Company�� network technology, it has helped connect a fragmented world of mortgage bankers, mortgage brokers, community banks, credit unions, lenders, investors and service providers, all of which are integral to the origination and funding of residential mortgages. Its Encompass360 solutions include Encompass Product & Pricing Service; Ellie Mae Total Quality Loan Program; Encompass Compliance Service; Encompass Appraisal Service; Encompass CenterWise; Encompass Commissions; Encompass TPO WebCenter and Encompass Docs Solution.
Ellie Mae�� Total Quality Loan program helps in identifying compliance, income and fraud issues early in the origination process; help protect business from loan buy-backs, and fortify workflow and uncover and correct possible issues before you close the loan.Encompass Appraisal Service, integrated inside Encompass360, is that solution helps in completing order right from the loan file in Encompass360; import complete appraisal reports directly into eFolder, and customize appraisal workflow by type of loan and control, which its users can order appraisals. Its Encompass CenterWise wraps two essential Web and electronic document solutions into one unified package. Encompass Commissions is a ! commission management solution integrated inside Encompass360 that automates the calculation, reconciliation and communication of variable pay across your organization. Hosted Encompass360 Banker Edition users can connect directly with third-party originators (TPOs) without leaving Encompass360, and have them connect back in a secure, synchronized, and easy-to-use Web-based environment. Encompass Docs Solution provides a single, integrated application incorporating both initial disclosures and closing documents.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on Ellie Mae (NYSE: ELLI ) , whose recent revenue and earnings are plotted below. - [By Lauren Pollock]
Among the companies with shares expected to actively trade in Friday’s session are WellCare Health Plans Inc.(WCG), First Solar Inc.(FSLR) and Ellie Mae Inc.(ELLI)
Top 5 Tech Stocks To Watch For 2014: International Rectifier Corporation (IRF)
International Rectifier Corporation designs, manufactures, and markets power management semiconductors worldwide. The company operates through six segments: Power Management Devices, Energy Saving Products, Automotive Products, Enterprise Power, HiRel, and Intellectual Property. The Power Management Devices segment provides power metal oxide semiconductor field effect transistors (MOSFETs), FETKYs, and DirectFETs for power supply, data processing, telecommunications, industrial, and commercial battery-powered systems. The Energy Saving Products segment provides analog high voltage integrated circuits (HVICs), insulated gate bipolar transistors (IGBTs) platforms, digital control ICs, and IRAM integrated power modules for motor control appliances, industrial automation, lighting and display, audio, and video applications. The Automotive Products segment offers HVICs, intelligent power switch ICs, power MOSFETs, IGBTs, diodes, and advanced power modules for various automotive applications. The Enterprise Power segment offers DirectFET discrete products, digital PWM controllers, power monitoring products, voltage regulators, low voltage ICs, and PowIRstages primarily for applications in servers, storage, routers, switches, infrastructure equipment, notebooks, graphic cards, and gaming consoles. The HiRel segment provides RAD-hard discretes, RAD-hard ICs, power management modules, DC-DC converters, and high temperature converters for satellites and space exploration vehicles, military hardware, and other high reliability applications. The Intellectual Property segment sells and licenses technologies and manufacturing process know-how. The company was founded in 1947 and is headquartered in El Segundo, California.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on International Rectifier (NYSE: IRF ) , whose recent revenue and earnings are plotted below.
Top 5 Tech Stocks To Watch For 2014: Location Based Technologies Inc (LBAS)
Location Based Technologies, Inc. (LBT), incorporated on April 20, 2006, designs, develops, and sells personal, pet, and vehicle locator devices and services including PocketFinder People, PocketFinder Pets and PocketFinder Vehicles. The Company markets and sells consumer and commercial location devices and services. Its devices utilize Assisted Global Positioning System (A-GPS) and General Packet Radio Service (GPRS) technologies in conjunction with its technologies designed to enhance the families to interact and stay connected around the world. The Company is a developer of the PocketFinder family of products and the PocketFinder Network. The PocketFinder family of products includes the PocketFinder People, PocketFinder Vehicle, PocketFinder Pets, PocketFinder Luggage, PocketFinder Mobile and PocketFinder Fleet. The PocketFinder is a small location device that enables a user to locate a device, person, or pet, at anytime from almost anywhere. PocketFinder personal locator devices are wireless.
The Company generate revenue by selling its products and charging customers an ongoing service fee, for which it offers monthly and annual subscription plans. The Company�� product, PocketFinder, is a small, waterproof and wireless location device that enables users to locate anyone or anything they care about, from a computer or Web-enabled device. Its products deliver critical information to users, such as: device location, longitude, latitude, heading speed and 60 days of location history. This information can be viewed passively through a user�� account or can be sent to a user via email or push notification if the user sets an alert. The target markets for the PocketFinder include: young children, seniors, people with special needs and people who need to track valuable assets such as luggage or sporting equipment. In addition to the PocketFinder, it also sell the PocketFinder Pet and the PocketFinder Vehicle products. The PocketFinder Pet is designed for pets weighing 15 pounds or more,! and it markets the PocketFinder Vehicle to families with new drivers, car enthusiasts, motorcycle owners, watercraft owners and business fleets. The PocketFinder Vehicle attaches directly to a battery or fuse box, so it has a constant supply of power. All PocketFinder products operate on the same user interface, which enables its customers receive the same features, functionality and user-experience, regardless of which product they own. To access their account or locate their devices, users can logon to the Company�� Website at www.pocketfinder.com or use its native iPhone, iPad or Android Apps.
The Company�� products are sold through various brick-and-mortar and online retailers and through its Website. It provides customer service and support in the United States through existing call centers owned by Affinitas. It provides wireless location based solutions for global positioning products along with its friendly user interface software system. PocketFinder and PocketFinder Vehicle devices are being sold in the United States and in Canada through the Apple Online Store and Apple Retail Stores. PocketFinder devices for Pets are available for purchase on its Website.
The Company competes with Geospatial Platform Providers, Application Developers, Garmin�� GTU-10, Qualcomm�� Tagg, Lo-Jack, SpotLight, Fleetmatics, NetworkFleet, and Qualcomm.
Advisors' Opinion:- [By CRWE]
Today, LBAS has shed (-7.69%) -0.010 at $.120 with 95,100 shares in play thus far (ref. google finance Delayed: 12:21PM EDT August 15, 2013).
Location Based Technologies, Inc. previously reported it has signed a distribution agreement with Beijing Lava Technology Co. Ltd., an Apple approved distributor for its online, brick and mortar stores, and authorized distributors in Asia. The agreement is one of the final steps preceding the launch of LBT�� GPS products into the Asian markets. Beijing Lava Technology Co. Ltd. serves China, Singapore, Japan, Korea, Taiwan, Malaysia, and Indonesia.
LBT estimates that it will begin selling its PocketFinder devices in Singapore through Apple�� online store and authorized distributors in the near future with other Asian countries to follow thereafter.
No comments:
Post a Comment